Vascular endothelial growth factor and renal cell carcinoma / 国际肿瘤学杂志
Journal of International Oncology
; (12): 148-151, 2012.
Article
en Zh
| WPRIM
| ID: wpr-418079
Biblioteca responsable:
WPRO
ABSTRACT
Vascular endothelial growth factor(VEGF) is high expressed in the organization of renal cell carcinoma and is mainly regulated by VHL gene and hypoxic of organization.Moreover,it can be used as a biomarker to judge renal cell carcinoma tumor progression and prognostic.In recent years,anti-VEGF targeted drugs are used for the treatment of renal cell carcinoma and receive meaningful clinical benefits.
Texto completo:
1
Banco de datos:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Año:
2012
Tipo del documento:
Article